Clinical Trials Directory

Trials / Completed

CompletedNCT02000908

Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy

Prospective, Randomized, Double Blind Study of Photobiomodulation Therapy Using the Realief Therapy System for the Treatment of Chemotherapy-associated Peripheral Neuropathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a 2-armed, randomized, sham-controlled, double-blinded clinical trial of photobiomodulation therapy using the Realief Therapy system. The patients will be randomized in a 3:4 ratio to treatment or sham arms.

Detailed description

The treatments will be administered by a Realief Neuropathy Center therapist. The target surface area and treatment durations will be dictated by the Realief Therapy protocol according to their proprietary algorithm, which includes assessment of geographic areas involved and the degree of neuropathy experienced. For the trial, each patient will be given 18 treatments of 30-minute duration, scheduled every three times weekly. The treatments will include laser exposure of any or all of 27 differentiated areas of the legs, feet, cervical spine region and lumbar spine region, for durations of 3 to 30 minutes, based on the symptom presentation at the time. Power densities will vary from 5 to 12 watts, based on the symptom presentations through the course of therapy.

Conditions

Interventions

TypeNameDescription
DEVICEphotobiomodulationThe photobiomodulation delivered by Realief Therapy involves amplitude wavelength light delivered by a class IV therapeutic laser.
OTHERSham treatmentAll patients in sham treatment arm cross over to laser therapy followed by physiotherapy
OTHERPhysiotherapyChiropractic massage and lymphedema treatment

Timeline

Start date
2014-01-01
Primary completion
2016-01-07
Completion
2017-01-06
First posted
2013-12-04
Last updated
2019-02-11
Results posted
2019-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02000908. Inclusion in this directory is not an endorsement.